Abstract
Tea is a widely renowned functional beverage originating from processed tender leaves of the Camellia sinensis plant after brewing with hot water. This refreshing and revitalizing beverage has been recognized as an essential commodity since ancient times. Tea constituents have many health benefits and hence find usage in functional foods, beverages, and nutraceuticals. Nonetheless, the clinical usage of tea constituents is limited by the high molecular weight, poor stability, and low bioavailability of some active components. We review how fresh tea leaves are processed into different forms of tea such as green, oolong, white, and black teas. The major tea constituents, e.g., catechins, caffeine, and theanine, exhibit numerous health properties such as antioxidant, anti-inflammatory, anticancer, antidiabetic, cardioprotective, and antimicrobial. We discuss methods to enhance the efficacy and applicability of active tea constituents, such as micro- and nanoencapsulation techniques.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Tea comes from the Camellia sinensis plant, which is native to Southeast Asia. Fresh tender leaves of this plant are processed for manufacture of different types of teas. The major occurring phytoconstituents of the tea leaves are catechins, which are a subclass of flavonoids (Stodt and Engelhardt 2013). Apart from catechins, other main constituents present in tea are caffeine and theanine (Rana et al. 2016). A wide array of research studies in the past have revealed the diverse health beneficial properties associated with tea consumption (Sharma and Rao 2009; Shahidi et al. 2009; Engelhardt 2010). Studies have reported the role of major tea constituents in the prevention and delay of various metabolic ailments such as obesity, diabetes, hypertension, atherosclerosis, and cancer (Zhen 2002; Demeule et al. 2002; Stangel et al. 2007; Shahidi et al. 2009; Sharma and Rao 2009; Chacko et al. 2010; Engelhardt 2010; Jankun et al. 2012).
However, despite the numerous pharmacological properties of tea constituents, its clinical applications have sprints likewise other natural products such as limited solubility and poor membrane permeability (Lohith Kumar and Sarkar 2018; Saka and Chela 2020; Paroha et al. 2020). This hindrance in the clinical and therapeutic delivery of tea constituents is due to their poor solubility, bioavailability, and efficacy (Bhushani et al. 2016; Son et al. 2016). Hence, it is very necessary to develop new sustainable techniques for improving the therapeutic delivery of these invaluable natural compounds. This article is an abridged version of the book chapter by Rana and Kumar (2020) in the series Sustainable Agriculture Reviews (https://www.springer.com/series/8380).
Different forms of teas
The manufacturing process of tea varies from country to country, and based on processing techniques, teas are classified as green, black, oolong, and white teas (Sajilata et al. 2008; Chen et al. 2011). All types of teas are prepared from tender leaves comprised of an unopened leaf (apical bud) and subtending two to three leaves of the same plant Camellia sinensis (Engelhardt 2010; Rana et al. 2016). Due to variability in processing, different teas impart different colors, tastes, and aromas (Feng et al. 2019). The most prevalent tea (green tea) is manufactured in a way that the majority of natural constituents present in green leaves remain unchanged during processing. Thus, freshly plucked tender tea shoots are heat-treated immediately after plucking to inactivate the endogenous enzymes (polyphenol oxidase and peroxidases) through different enzyme inactivation techniques (Gulati et al. 2003; Shitandi et al. 2013) before rolling and final drying steps.
Black tea is further of two types: CTC (cut/crush, tear, and curl) black tea and orthodox black tea. The CTC black tea is manufactured by using a CTC machine which cuts the leaves into small pieces, followed by crushing and rolling into tea granules before drying (Baruah and Mahanta 2003; Engelhardt 2010). CTC tea generally produces a rich reddish-orange-colored infusion when brewed with hot water, whereas the processing of orthodox black or leaf tea involves withering of freshly plucked tea shoots for up to 12–16 h to remove excess moisture up to 50% by weight. Withering is followed by the rolling of tea shoots in tea rollers. The rolling step leads to the instigation of numerous biochemical reactions and hereby initiates the process for the formation of various aroma, flavors, and colored compounds (Carloni et al. 2013; Feng et al. 2019). The rolled tea is further oxidized for color enrichment before drying (Shitandi et al. 2013).
Oolong tea is the traditional form of Chinese tea (Chen et al. 2011; Zhen 2002). This tea processing lies between green and black tea and is manufactured by partial enzyme inactivation (Chen et al. 2011; Carloni et al. 2013; Weerawatanakornet al. 2015). The partially withered tea shoots are processed by rolling before drying with hot air. White tea is a special tea made selectively from apical buds (newborn leaves). For the manufacturing of white tea, the apical buds are collected by handpicking. The whole buds are withered for a few hours and then rolled gently (Carloni et al. 2013; Feng et al. 2019).
Chemistry of major tea constituents
A diverse array of phytochemicals are known to be present in green tea leaves. Among them, catechins along with caffeine and theanine occur predominantly. These foremost tea constituents are also responsible for the taste, color, and aroma of the brewed tea infusion (Pinto 2013; Vuong et al. 2011). Apart from these major constituents, various other compounds are also reported in tea like organic acids, carbohydrates, polysaccharides, minerals, saponins, methylxanthines, proteins, and lipids (Zhen 2002). Catechins are the predominant flavanols derivatives of flavonoids, characterized by meta-5,7-dihydroxy-substituted A-ring with di- or trihydroxylic B-ring (Verloop et al. 2016) and biosynthesized from the basic skeleton of chalcone (Rammohan et al. 2020). They are also called flavan-3-ols due to the occurrence of the hydroxyl group at the third position of the C-ring (Panche et al. 2016). Catechins constitute a group of monomeric flavanol derivatives comprising of epigallocatechin (EGC), epicatechin (EC), epigallocatechin gallate (EGCG), and epicatechin gallate (ECG) (Zhen 2002). The content of catechins in tea leaves is influenced by leaf age, harvest season, and manufacturing processes of tea (Rana et al. 2016; Wakamatsu et al. 2019). The outmost content of these molecules occurs in new tender tea leaves (12–15%) which are normally used for tea manufacture as compared to coarse and mature tea leaves (Rana et al. 2016). Epigallocatechin gallate is the most abundant and highly investigated tea molecule that constitutes up to 50% of all catechins (Singh et al. 2011). Caffeine (1,3,7-trimethylxanthine) is an alkaloid molecule (Engelhardt 2010). It is one of the most widely consumed active food ingredients with various health beneficial properties (Zhen 2002). Caffeine helps in enhancing mood and alertness by acting mainly upon the central nervous system (Heckman et al. 2010). Theanine is another very important compound that occurs exclusively in tea (Engelhardt 2010), and apart from tea it has been reported in a mushroom, Xerocomus badius. It is a non-protein amino acid, which imparts umami taste to tea (Zhen 2002). Theanine consumption has been associated with brain relaxation and improving learning ability (Voung et al. 2011).
Pharmacological activities of tea constituents
Tea is widely recognized for a diverse array of health beneficial properties (Fig. 1). Tea consumption has been associated with the prevention and delay of various metabolic diseases. It includes lower risk of cardiovascular diseases like stroke, atherosclerosis, helps in inhibition of inflammation, prevention of cancer, and associated diseases (Ruxton 2008; Sharma and Rao 2009). These pharmacological properties have been associated with the high content of phenolic compounds in tea. It has been evident from various in vitro, in vivo, and animal model studies that tea phenolics have powerful therapeutic potential and have direct effects on various biochemical processes that occur via a range of complex mechanisms (Vuong 2014).
Antioxidant activity
Antioxidants are chemical compounds responsible for scavenging free radicals such as reactive oxygen species and reactive nitrogen species that are generated in the body (Lobo et al. 2010). They have a strong ability to terminate oxidation chain reactions by removing free radical intermediates, and also inhibit other cellular oxidation reactions (Halliwell et al. 1995). They attain this by getting oxidized themselves. The tea phenolics are well-recognized antioxidant compounds. Numerous research reports illustrate the antioxidant behavior of tea phenolics (Wiseman et al. 1997; Rietveld and Wiseman 2003; Wang et al. 2006; Sharma and Rao 2009; Chu et al. 2017). Catechins are the major polyphenolic antioxidant compounds present in tea with ability to donate proton or hydrogen, due to high conjugation in their molecular structure that makes them potential antioxidant candidate (Sen et al. 2020; Yan et al. 2020).
Numerous epidemiological studies have revealed that tea polyphenols help in the protection of cells and tissue from oxidative damage of reactive oxygen species (Mao et al. 2017; Yan et al. 2020). Due to their free radical scavenging behavior, tea polyphenols can act as a natural and reliable source of potent antioxidant compounds (Yan et al. 2020). Tea consumption is also related to the protection during alcohol intoxication by preventing the reduction of liver glutathione peroxidase, reductase, and catalase activity, which would otherwise deplete the cellular antioxidant defense system, especially in the liver (Luczaj and Skrzydlewska 2004).
Anti-inflammatory activity
Inflammation is the cellular response of our body that involves the influx of defensive cells like leukocytes (neutrophils, monocytes, and eosinophils) to the site of injury (Chaplin 2010). Any disturbance in these cellular mechanisms or prolonged inflammation leads to implications, which could cause cancer and other diseased conditions (Chen et al. 2017). Generation of nitric oxide and prostaglandins by inducible nitric oxide synthase (iNOS) and cyclooxygenase-2 is considered as the most prominent molecular mechanisms involved in inflammation and cancer (Ahmed et al. 2002; Zhong et al. 2012). It was reported that green tea exhibits anti-inflammatory effects by inhibiting the expression of iNOS (Tedeschi et al. 2004).
From the extensive epidemiological data, it has been established that green and black tea polyphenols play a significant role in the suppression of inflammation by inhibition of various transcription factors like tumor necrosis factor-α, granulocyte–macrophage colony-stimulating factor, and cyclooxygenase-2 (Cao et al. 2007; Novilla et al. 2017). However, exact molecular mechanisms explicating the role of tea polyphenols in inflammation is not very clear till now. It has been recognized that drinking a sufficient amount of tea might be helpful in the prevention of inflammation, which is also responsible for causing various other disease conditions.
Anticancer activity
Cancer is a disease condition wherein the cells of any specific tissue of the body start uncontrolled growth and division (Anantharaju et al. 2016). These cells are recognized as cancerous as they can invade and destroy surrounding healthy cells, tissues, and organs as well (Cooper 2000). A diverse range of research articles are available in the literature reporting that tea and its constituents have positive effects in inhibition of tumorigenesis at various sites in the body, including skin, mammary gland, lung, oral cavity, esophagus, stomach, small intestine, colon, liver, prostate, and pancreas (Yang et al. 2002; Demeule et al. 2002; Boehm et al. 2010). Various clinical trials have been conducted in the past on both human and animal models for the investigation of possible anticancer properties of tea constituents (Demeule et al. 2002; Bettuzzi et al. 2006). Nonetheless, the use of tea polyphenols as therapeutics has to explore its perspectives in prevention and delay of cancer which is among the major killer of millions of people globally (Miyata et al. 2018). Epigallocatechin gallate was reported to induce apoptosis and inhibit cell proliferation in different human cancer cell lines and also showed inhibitory effects on angiogenesis and metastasis (Singh et al. 2011). Epigallocatechin gallate is also found to inhibit the malignant transformation/cell proliferation by targeting transcription factors nuclear factor-kappa B and activator protein-1 and exhibits chemopreventive actions (Surh 2006). Regardless of the large number of research data demonstrating the significant role of tea and its polyphenols against cancer progression, still there is a long way to comprehend the unknown mechanisms behind cancer occurrence (Boehm et al. 2010; Yang and Wang 2011).
Antidiabetic activity
Diabetes is a disease state wherein the blood glucose level of the patient is higher than the normal level (Musman et al. 2019). This situation may usually arise due to the inability of the body to pick up extra glucose from the bloodstream or inability in glucose metabolism. Studies have found that diabetes has emerged as one of the leading cause of global deaths that occurs annually (Tripathy 2018). In the last two decades, various studies have found that tea, especially green tea, plays a significant role in the prevention of diabetes (Miura et al. 2005; Islam and Choi 2007). Various investigators reported the preventive and curative properties of tea polyphenols against diabetes (Chacko et al. 2010; Jankun et al. 2012). The documented research data showed that the consumption of tea is correlated with the prevention of diabetes.
Obesity is one of the main causes of insulin resistance that leads to the production of various pro-inflammatory cytokines such as tumor necrosis factor-α, interleukin 1, and interleukin 6, which eventually inhibits insulin signaling (Al-Goblan et al. 2014). Earlier studies revealed that tea and its constituents showed insulin-enhancing activity, lower plasma glucose level, and inhibit the level of inflammatory cytokines (Liu et al. 2013; Anderson et al. 2002; Suzuki et al. 2016; Molina et al. 2015). Sharma et al. (2019) reported that green tea catechins increase insulin secretion, control blood glucose levels, and also help in improving insulin resistance in type 2 diabetes mellitus patients. Tea catechins were also reported to inhibit the enzymes involved in carbohydrate digestion and decrease glucose absorption in the intestine (Sharma et al. 2019). These factors are directly linked with the occurrence of diabetes; therefore, it is stipulated that tea consumption helps in the prevention of diabetes. There is still a lack of sufficient data in support of proper cellular and molecular mechanisms related to the prevention of diabetes in humans by tea constituents.
Cardioprotective effects
Cardiovascular diseases are the ailment of the heart and blood vessels and are generally distinguished as coronary heart diseases, cerebrovascular diseases, hypertension, and heart failure (Beyer 2016). These causes are directly associated with our diet and lifestyle responsible for the elevated occurrence of cardiovascular diseases among populations (Buttar 2005). The major reasons for the high prevalence of cardiovascular diseases are high blood pressure, high cholesterol, diabetes, extensive smoking, and family history (Buttar 2005; Hajar 2017). Tea and its polyphenols have been recognized as a potent and reliable source to fight against cardiovascular diseases (Yan et al. 2020). A large number of research data have been available supporting tea and its constituents and their role in the prevention of these disease conditions. The tea polyphenols could act as possible cardioprotective candidates due to their potent antioxidant capacity (Yan et al. 2020). They induce antioxidative effects by scavenging reactive oxygen species and chelating metal ions (Velayutham et al. 2008). It has been found that free radicals play a key role in the occurrence of cardiovascular disorders by causing oxidative stress (Aron and Kennedy 2008). Due to the repetitive induction of cellular oxidative stress, there occurs induced cellular resistance to consequent exposure to reactive oxygen species. This could be inhibited by galloyl group in tea polyphenols (Stangl et al. 2007). The galloyl group may be interfering by modifying kinase activities in multiple pathways of signal transduction in cardiovascular relevant cells which could play a crucial role in the prevention and treatment of cardiovascular diseases (Stangl et al. 2007). Tea catechins were reported to improve blood lipid profile by inhibiting the main enzymes involved in the biosynthesis of lipids (Velayutham et al. 2008). Tea flavan-3-ols were reported to decrease blood cholesterol levels and avoid the accumulation of cholesterol in the liver and heart in rat models with hypercholesterolemia (Velayutham et al. 2008). Earlier studies reported that consumption of green tea catechins is associated with a reduction in total and low-density lipoprotein (Kim et al. 2011). Endothelial dysfunction is substantially correlated to the pathogenesis of cardiovascular diseases (Hadi et al. 2005). Earlier findings suggest the beneficial effect of tea catechins in patients with cardiovascular diseases by improving endothelial dysfunction (Widlansky et al. 2007; Babu et al. 2008). Thus, tea polyphenols have a huge perspective to be used as preventive therapeutics against cardiovascular disorders.
Antimicrobial activity
Antimicrobial behavior is the ability of tea polyphenols to act against harmful microorganisms such as bacteria, fungi, and viruses and inhibit their progression. The role of tea polyphenols in the growth inhibition of various infectious microorganisms has been thoroughly reported in numerous earlier reports (Liu et al. 2005; Friedman 2007). The tea polyphenols regulate the gene expression in Escherichia coli, inhibits cellular division in some species of bacteria, and also inhibit human immunodeficiency virus-1 replication in the human body by targeting at various steps in the life cycle of human immunodeficiency virus-1 which is the major causative agent of acquired immunodeficiency syndrome (Liu et al. 2005). Tea polyphenols also act synergistically with selective antibiotics and show benefits against multidrug resistance. Earlier, Tiwari et al. (2005) reported the synergistic activity of tea extracts with chloramphenicol and other antibiotics like methicillin, nalidixic acid, and gentamycin against various strains of enteropathogens. In another study, Betts et al. (2013) found synergistic antifungal effects of black tea theaflavin and green tea epicatechin against Candida albicans in combination. Thus, it is evident that tea and its constituents have a good perspective to be used as antimicrobials.
Therapeutic delivery of tea constituents
A plethora of in vitro studies revealed the potential therapeutic benefits of tea catechins in the prevention of various ailments (Baldi et al. 2020). The majority of pharmacological properties of tea constituents are associated with the antioxidant behavior of tea catechins due to the presence of phenolic groups (Yan et al. 2020). This polyphenolic nature of catechins is concomitant with the low efficacy and bioavailability of tea catechins (Bhushani et al. 2016; Son et al. 2016; Cai et al. 2018a, b). It also affects the therapeutic application of tea catechins. Thus, low bioavailability, poor bioaccessibility, and inconsistent systemic release of tea catechins, especially epigallocatechin gallate, have restricted their clinical applications (Bhushani et al. 2016; Son et al. 2016). To overcome these shortcomings, considerable work is done in recent past for processing of tea constituents for enhancing their bioavailability, cell permeability, and inhibition of gastrointestinal degradation (Fig. 2). Various matrix-assisted encapsulation techniques have been used in the recent past to overcome this issue (Table 1). Generally, carbohydrate (chitosan, cellulose polymers, starch-based materials, gum arabic, and sodium alginate), protein, lipids, and gelatin derivatives are widely employed for encapsulation of tea constituents (Cai et al. 2018a, b).
In a recent study by Ahmad et al. (2019), starch-based nanoparticles were prepared for nanoencapsulation of catechin. Results showed that during simulated gastrointestinal digestion, the biological properties of catechins were retained in encapsulated catechin compared to free catechin. In another study, chitosan was used for the nanoencapsulation of catechin that exhibited good surface topography and emulsion stability (Kailaku et al. 2014). Encapsulation of green tea catechins in γ-cyclodextrin and coating with hydroxypropylmethylcellulose phthalate were reported to increase their digestive stability up to 65% and 58%, respectively (Son et al. 2016). Bovine serum albumin, a globular protein, was efficiently used as an effective carrier for encapsulation of epigallocatechin gallate. It was reported that the stability of epigallocatechin gallate was enhanced when bound to bovine serum albumin compared to free one (Yi et al. 2017). Moreover, chitosan-coated bovine serum albumin–epigallocatechin gallate nanoparticles improved the absorption of epigallocatechin gallate. It was showed that chitosan-coated BSA–epigallocatechin gallate nanoparticles showed higher permeability compared to the free form of epigallocatechin gallate (Li et al. 2014). Thus, it is clear that matrix encapsulation of tea constituents helps in enhancing their stability and bioaccessibility.
Perspectives
Numerous epidemiological research evidence in recent years indicated that regular consumption of tea and its constituents could help in the prevention and delay of various diseases such as diabetes, obesity, hypertension, cardiovascular disorders, and cancer. Since tea is an inexpensive and sustainable bioresource to obtain these highly valuable natural antioxidants, there is an immense need to intensify the research efforts to cope with the issues of poor stability, efficacy, and bioavailability of tea constituents. The outcome of these research studies will open new horizons for exploration and valorization of tea constituents as therapeutics against miscellaneous health ailments.
Conclusions
Tea is undoubtedly a health-promoting beverage, which constitutes a diverse array of bioactive molecules. The tea shoots are processed for the preparation of various types of teas (green, black, oolong, and white) with different manufacturing processes. These teas constitute a wide array of volatile and non-volatile chemical compounds and impart unique taste and aroma. Various research studies have revealed the role of different teas and their chemical constituents in the prevention and delay of metabolic ailments at the cellular and molecular levels. Contrariwise poor bioavailability, low bioaccessibility, and incongruous systemic release of tea constituents due to their large molecular weight and number of phenolic groups limit their therapeutic applications. Hence, new and sustainable techniques to resolve the issue of poor stability and bioefficacy of tea constituents for extensive clinical applications are indeed necessary for their applications in the development of new functional foods, pharmaceuticals, and nutraceuticals.
References
Ahmad M, Mudgil M, Gani A, Hamed F, Masood FA, Maqsood S (2019) Nanoencapsulation of catechin in starch nanoparticles: characterization; release behavior and bioactivity retention during in-vitro digestion. Food Chem 270:95–104. https://doi.org/10.1016/j.foodchem.2018.07.024
Ahmed S, Rehman A, Hasnain A, Lalonde M, Goldberg VM, Haqqi TM (2002) Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1β-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic Bio Med 33:1097–1105. https://doi.org/10.1016/s0891-5849
Al-Goblan AS, Al-Alfi MA, Khan MZ (2014) Mechanism linking diabetes mellitus and obesity. Diabetes Metab Syndr Obes 7:587–591. https://doi.org/10.2147/DMSO.S67400
Anantharaju PG, Gowda PC, Vimalambike MG, Madhunapantula SV (2016) An overview on the role of dietary phenolics for the treatment of cancers. Nutr J 15:99. https://doi.org/10.1186/s12937-016-0217-2
Anderson RA, Polansky MM (2002) Tea enhances insulin activity. J Agric Food Chem 50:7182–7186. https://doi.org/10.1021/jf020514c
Aron PM, Kennedy JA (2008) Flavan-3-ols: nature, occurrence and biological activity. Mol Nut Food Res 52:79–104. https://doi.org/10.1002/mnfr.200700137
Babu PV, Liu D (2008) Green tea catechins and cardiovascular health: an update. Curr Med Chem 18:1840–5180. https://doi.org/10.2174/092986708785132979
Baldi A, Abramovic H, Poklar Ulrih N, Daglia M (2020) Tea catechins. In: Xiao J, Sarker S, Asakawa Y (eds) Handbook of dietary phytochemicals. Springer, Singapore. https://doi.org/10.1007/978-981-13-1745-3_19-3
Baruah AM, Mahanta PK (2003) Fermentation characteristics of some assamica clones and process optimization of black tea manufacturing. J Agric Food Chem 51(22):6578–6588. https://doi.org/10.1021/jf030019w
Betts JW, Wareham DW, Haswell SJ, Kelly SM (2013) Antifungal synergy of theaflavin and epicatechin combinations against Candida albicans. J Microbiol Biotechnol 23:1–5. https://doi.org/10.4014/jmb.1303.03010
Bettuzzi S, Brausi M, Rizzi F, Castagnetti G, Peracchia G, Corti A (2006) Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study. Cancer Res 66:1234–1240. https://doi.org/10.1158/0008-5472.CAN-05-1145
Beyer KMM (2016) Chronic environmental diseases: burdens, causes, and response. In: Shroder JF, Sivanpillai R (eds) Biological and environmental hazards, risks, and disasters. Elsevier, New York, pp 191–217
Bhushani JA, Karthik P, Anandharamakrishnan C (2016) Nanoemulsion based delivery system for improved bioaccessibility and Caco-2cell monolayer permeability of green tea catechins. Food Hydrocoll 56:372–382. https://doi.org/10.1016/j.foodhyd.2015.12.035
Boehm K, Borrelli F, Ernst E, Habacher G, Hung SK, Milazzo S, Horneber M (2010) Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD005004.pub2
Buttar HS, Li T, Ravi N (2005) Prevention of cardiovascular diseases: role of exercise, dietary interventions, obesity and smoking cessation. Exp Clin Cardiol 10:229–249
Cai Z-Y, Li X-M, Liang J-P, Xiang L-P, Wang K-R, Shi Y-L, Yang R, Shi M, Ye J-H, Lu J-L, Zheng X-Q, Liang Y-R (2018a) Bioavailability of tea catechins and its improvement. Molecules 23:2346. https://doi.org/10.3390/molecules23092346
Cai ZY, Li XM, Liang JP, Xiang LP, Wang KR, Shi YL, Yang R, Shi M, Ye JH, Lu JL, Zheng XQ, Liang YR (2018b) Bioavailability of tea catechins and its improvement. Molecules 23(9):2346. https://doi.org/10.3390/molecules23092346
Cao H, Kelly MA, Kari F, Dawson HD, Urban JF Jr, Coves S, Roussel AM, Anderson RA (2007) Green tea increases anti-inflammatory tristetraprolin and decreases pro-inflammatory tumor necrosis factor mRNA levels in rats. J Inflamm 4:1–12. https://doi.org/10.1186/1476-9255-4-1
Carloni P, Tiano L, Padella L, Bacchetti T, Customu C, Kay A, Damiani E (2013) Antioxidanactivity of white, green and black tea obtained from the same tea cultivar. Food Res Int 53(2):900–908. https://doi.org/10.1016/j.foodres.2012.07.057
Chacko SM, Thambi PT, Kuttan R, Nishigaki I (2010) Beneficial effects of green tea: a literature review. Chin Med 5:1–9. https://doi.org/10.1186/1749-8546-5-13
Chaplin DD (2010) Overview of the immune response. J Allergy Clin Immunol 125:S3–S23. https://doi.org/10.1016/j.jaci.2009.12.980
Chaturvedula VSP, Prakash I (2011) The aroma, taste, color and bioactive constituents of tea. J Med Plants Res 5:2110–2124. https://doi.org/10.5897/JMPR.9001187
Chavva SR, Deshmukh SK, Kanchanapally R, Tyagi N, Coym JW, Singh AP, Singh S (2019) Epigallocatechin gallate-gold nanoparticles exhibit superior antitumor activity compared to conventional gold nanoparticles: Potential synergistic interactions. Nanomaterials 9:396. https://doi.org/10.3390/nano9030396
Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, Li Y, Wang X, Zhao L (2017) Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 14:7204–7218
Chen YL, Duan J, Jiang YM, Shi J, Peng L, Xue S, Kakuda Y (2011) Production, quality, and biological effects of Oolong tea (Camellia sinensis). Food Rev Int 27:1–15. https://doi.org/10.1080/87559129.2010.518294
Chu C, Deng J, Man Y, Qu Y (2017) Green tea extracts epigallocatechin-3-gallate for different treatments. Bio Med Res Int. https://doi.org/10.1155/2017/5615647
Cooper GM (2000) The development and causes of cancer. In: Cooper GM (ed) The Cell: A Molecular Approach. 2nd edition. Sunderland (MA): sinauer Associates. https://www.ncbi.nlm.nih.gov/books/NBK9963/
Dag D, Oztop MH (2017) Formation and characterization of green tea extract loaded liposomes. J Food Sci 82:463–470. https://doi.org/10.1111/1750-3841.13615
Demeule M, Michaud-Levesque J, Annabi B, Gingras D, Boivin D, Jodoin J, Lamy S, Bertrand Y, Beliveau R (2002) Green tea catechins as novel antitumor and antiangiogenic compounds. Curr Med Chem Anticancer Agents 2:441–463. https://doi.org/10.2174/1568011023353930
Engelhardt UH (2010) Chemistry of tea. In: Lew M, Hung-Wen L (eds) Comprehensive natural products II. Elsevier, Oxford, pp 999–1032
Feng Z, Li Y, Li M, Wang Y, Zhang L, Wan X, Yang X (2019) Tea aroma formation from six model manufacturing processes. Food Chem 285:347–354. https://doi.org/10.1016/j.foodres.2012.07.057
Friedman M (2007) Overview of antibacterial, antitoxin, antiviral, and antifungal activities of tea flavonoids and teas. Mol Nutr Food Res 51:116–134. https://doi.org/10.1002/mnfr.200600173
Gomes JFPS, Rochaa S, Pereiraa MDC, Peres I, Moreno S, Toca-Herrera J, Coelho MAN (2010) Lipid/particle assemblies based on maltodextrin–gum arabic core as bio-carriers. Colloid Surface B 76:449–455. https://doi.org/10.1016/j.colsurfb.2009.12.004
Gulati A, Rawat R, Singh B, Ravindranath SD (2003) Application of microwave energy in the manufacture of enhanced-quality green tea. J Agric Food Chem 51:4764–4768. https://doi.org/10.1186/s40529-016-0143-9
Hadi HA, Carr CS, Al Suwaidi J (2005) Endothelial dysfunction: cardiovascular risk factors, therapy, and outcome. Vasc Health Risk Manag 1:183–198
Hajar R (2017) Risk Factors for coronary artery disease: historical perspectives. Heart views 18:109–114. https://doi.org/10.4103/HEARTVIEWS.HEARTVIEWS_106_17
Halliwell B (1995) How to characterize an antioxidant: an update. Biochem Soc Symp 61:73–101. https://doi.org/10.1042/bss0610073
Haratifar S, Meckling KA, Corredig M (2014) Antiproliferative activity of tea catechins associated with casein micelles, using HT29 colon cancer cells. J Dairy Sci 97:672–678. https://doi.org/10.3168/jds.2013-7263
Heckman MA, Weil J, Demejia EG (2010) Caffeine (1, 3, 7-trimethylxanthine) in foods: A comprehensive review on consumption, functionality, safety, and regulatory matters. J Food Sci 75:R77–R87. https://doi.org/10.1111/j.1750-3841.2010.01561.x
Hong Z, Xu Y, Yin J-F, Jin J, Jiang Y, Du Q (2014) Improving the Effectiveness of (−)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic Acid. J Agric Food Chem 62:12603–12609. https://doi.org/10.1021/jf504603n
Hsieh DS, Wang H, Tan SW, Huang YH, Tsai CY, Yeh MK, Wu CJ (2011) The treatment of bladder cancer in a mouse model by epigallocatechin-3-gallate-gold nanoparticles. Biomaterials 32:7633–7640. https://doi.org/10.1016/j.biomaterials.2011.06.073
Islam MS, Choi H (2007) Nongenetic model of type 2 diabetes: a comparative study. Pharmacology 79:243–249. https://doi.org/10.1159/000101989
Jankun J, Al-Senaidy A, Skrzypczak-Jankun E (2012) Can drinking black tea fight diabetes: literature review and theoretical indication. Cent Eur J Immunol 37:167–172
Kailaku SI, Mulyawanti I, Alamsyah AN (2014) Formulation of nano encapsulated catechin with chitosan as encapsulation material. Procedia Chem 9:235–241. https://doi.org/10.1016/j.proche.2014.05.028
Kim A, Chiu A, Barone MK, Avino D, Wang F, Coleman CI, Phung OJ (2011) Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc 111:1720–1729. https://doi.org/10.1016/j.jada.2011.08.009
Lee J, Chambers D, Chambers E (2013) Sensory and instrumental flavor changes in green tea brewed multiple times. Foods 2:554–571
Li Z, Ha J, Zou T, Gu L (2014) Fabrication of coated bovine serum albumin (BSA)-epigallocatechin gallate (EGCG) nanoparticles and their transport across monolayers of human intestinal epithelial Caco-2 cells. Food Funct 5:1278–1285. https://doi.org/10.1039/c3fo60500k
Liu B, Wang Y, Yu Q, Li D, Li F (2017) Synthesis, characterization of catechin-loaded folate-conjugated chitosan nanoparticles and their anti-proliferative effect. Cyta J Food 16:868–876. https://doi.org/10.1080/19476337.2018.1491625
Liu K, Zhou R, Wang B, Chen K, Shi L-Y, Zhu J-D, Mi M-T (2013) Effect of green tea on glucose control and insulin sensitivity: a meta-analysis of 17 randomized controlled trials. Am J Clin Nutr 98:340–348. https://doi.org/10.3945/ajcn.112.052746
Liu S, Lu H, Zhao Q, He Y, Niu J, Debnath AK, Wu S, Jiang S (2005) Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41. Biochim Biophys Acta 1723:270–281. https://doi.org/10.1016/j.bbagen.2005.02.012
Lobo V, Patil A, Phatak A, Chandra N (2010) Free radicals, antioxidants and functional foods: impact on human health. Pharmacogn Rev 4:118–126. https://doi.org/10.4103/0973-7847.70902
Lohith Kumar D, Sarkar P (2018) Encapsulation of bioactive compounds using nanoemulsions. Environ Chem Lett 16:59–70. https://doi.org/10.1007/s10311-017-0663-x
Luczaj W, Skrzydlewska E (2004) Antioxidant properties of black tea in alcohol intoxication. Food Chem Toxicol 42:2045–2051. https://doi.org/10.1016/j.fct.2004.08.009
Mao X, Gu C, Chen D, Yu B, He J (2017) Oxidative stress-induced diseases and tea polyphenols. Oncotarget 8:81649–81661
Miura T, Koike T, Ishida T (2005) Antidiabetic activity of green tea (Thea sinensis L.) in genetically type 2 diabetic mice. J Health Sci 51:708–710. https://doi.org/10.1248/jhs.51.708
Miyata Y, Matsuo T, Araki K, Nakamura Y, Sagara Y, Ohba K, Sakai H (2018) Anticancer effects of green tea and the underlying molecular mechanisms in bladder cancer. Medicines (Basel) 5:87. https://doi.org/10.3390/medicines5030087
Molina N, Bolin AP, Otton R (2015) Green tea polyphenols change the profile of inflammatory cytokine release from lyphocytes of obese and lean rats and protect against oxidative damage. Int Immunopharmacol 28:985–996. https://doi.org/10.1016/j.intimp.2015.08.011
Morin-Crini N, Lichtfouse E, Torri G, Crini G (2019) Applications of chitosan in food, pharmaceuticals, medicine, cosmetics, agriculture, textiles, pulp and paper, biotechnology, and environmental chemistry. Environ Chem Lett 17:1667–1692. https://doi.org/10.1007/s10311-019-00904-x
Musman M, Zakia M, Rahmayani RFI, Erlidawati E, Safrida S (2019) Pharmaceutical hit of anti type 2 diabetes mellitus on the phenolic extract of Malaka (Phyllanthus emblica L.) flesh. Clin Phytosci. https://doi.org/10.1186/s40816-019-0138-7
Novilla A, Djamhuri DS, Nurhayati B, Rihibiha DD, Afifah E, Widowati W (2017) Anti-inflammatory properties of oolong tea (Camellia sinensis) ethanol extract and epigallocatechin gallate in LPS-induced RAW 264.7 cells. Asian Pac J Trop Biomed 7:1005–1009. https://doi.org/10.1016/j.apjtb.2017.10.002
Panche AN, Diwan AD, Chandra SR (2016) Flavonoids: an overview. J Nutr Sci 5:e47. https://doi.org/10.1017/jns.2016.41
Paroha S, Dewangan RP, Dubey RD, Sahoo PK (2020) Conventional and nanomaterial-based techniques to increase the bioavailability of therapeutic natural products: a review. Environ Chem Lett 18:1767–1778. https://doi.org/10.1007/s10311-020-01038-1
Pinto MS (2013) Tea: a new perspective on health benefits. Food Res Int 53:557–568. https://doi.org/10.1016/j.foodres.2013.01.038
Radhakrishnan R, Kulhari H, Pooja D, Gudem S, Bhargava S, Shukla R, Sistla R (2016) Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer. Chem Phys Lipids 198:51–60. https://doi.org/10.1016/j.chemphyslip.2016.05.006
Rammohan A, Reddy JS, Sravya G, Rao CN, Zyryanov GV (2020) Chalcone synthesis, properties and medicinal applications: a review. Environ Chem Lett 18:433–458. https://doi.org/10.1007/s10311-019-00959-w
Rana A, Kumar S (2020) Chemistry, pharmacology and therapeutic delivery of major tea constituents. In: Saneja A, Panda A, Lichtfouse E (eds) Sustainable agriculture reviews 43. Springer, Cham
Rana A, Sharma E, Rawat K, Sharma R, Verma S, Padwad Y, Gulati A (2016) Screening and purification of catechins from underutilized tea plant parts and their bioactivity studies. J Food Sci Technol 53:4023–4032. https://doi.org/10.1007/s13197-016-2406-6
Rana A, Singh HP, Gulati A (2015) Concurrent analysis of theanine, caffeine, and catechins using hydrophobic selective C12 stationary phase. J Liq Chromatogr Relat Technol 38:709–715. https://doi.org/10.1080/10826076.2014.962144
Rawat R, Gulati A, Babu GDK, Acharya R, Kaul VK, Singh B (2007) Characterization of volatile components of Kangra orthodox black tea by gas chromatography-mass spectrometry. Food Chem 105:229–235. https://doi.org/10.1016/j.foodchem.2007.03.071
Rietveld A, Wiseman S (2003) Antioxidant effects of tea: evidence from human clinical trials. J Nutr 133:3285S-3295S. https://doi.org/10.1093/jn/133.10.3285S
Ruxton CHS (2008) Black tea and health. Nutr Bull 33:91–101. https://doi.org/10.1111/j.1467-3010.2008.00691.x
Sabouri S, Wright AJ, Corredig M (2017) In vitro, digestion of sodium caseinate emulsions loaded with epigallocatechin gallate. Food Hydrocoll 69:350–358. https://doi.org/10.1016/j.foodhyd.2017.02.008
Sajilata MG, Bajaj PR, Singhal RS (2008) Tea Polyphenols as nutraceuticals. Compr Rev Food Sci Food Saf 7:229–254. https://doi.org/10.1111/j.1541-4337.2008.00043.x
Saka R, Chella N (2020) Nanotechnology for delivery of natural therapeutic substances: a review. Environ Chem Lett. https://doi.org/10.1007/s10311-020-01103-9
Sen G, Sarkar N, Nath M, Maity S (2020) Bioactive components of tea. Arch Food Nutr Sci 4:001–009
Shahidi F, Lin JK, Ho CT (2009) Tea and tea products: Chemistry and health-promoting properties. CRC Press, Florida
Sharma V, Gupta AK, Walia A (2019) Effect of green tea on diabetes mellitus. Acta Sci Nutr Health 3:27–31
Sharma V, Rao LJM (2009) A Thought on the biological activities of black tea. Crit Rev Food Sci Nutr 49:379–404. https://doi.org/10.1080/10408390802068066
Sherry Chow H-H, Hakim IA, Vining DR, Crowell JA, Tome ME, Ranger-Moore J, Cordova CA, Mikhael DM, Briehl MM, Alberts DS (2007) Modulation of human glutathione S-transferases by polyphenon E intervention. Cancer Epidemiol Biomarkers Prev 16:1662–1666. https://doi.org/10.1158/1055-9965.EPI-06-0830
Shi M, Huang LY, Nie N, Ye JH, Zheng XQ, Lu JL, Liang YR (2017) Binding of tea catechins to rice bran protein isolate: Interaction and protective effect during in vitro digestion. Food Res Int 93:1–7. https://doi.org/10.1016/j.foodres.2017.01.006
Shitandi AA, Ngure MF, Mahungu SM (2013) Tea processing and its Impact on catechins, theaflavin and thearubigin formation. In: Preedy VR (ed) Tea in health and disease prevention. Academic Press, pp 193–205. https://doi.org/10.1016/B978-0-12-384937-3.00016-1
Singh BN, Shankar S, Srivastava RK (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82(12):1807–1821. https://doi.org/10.1016/j.bcp.2011.07.093
Son Y-R, Chung J-H, Ko S, Shim S-M (2016) Combinational enhancing effects of formulation and encapsulation on digestive stability and intestinal transport of green tea catechins. J Microencapsul 33:183–190. https://doi.org/10.3109/02652048.2016.1144816
Stangl V, Dreger H, Stangl K, Lorenz M (2007) Molecular targets of tea polyphenols in the cardiovascular system. Cardiovasc Res 73:348–358. https://doi.org/10.1016/j.cardiores.2006.08.022
Stodt U, Engelhardt UH (2013) Progress in the analysis of selected tea constituents over the past 20 years. Food Res Int 53:236–248. https://doi.org/10.1016/j.foodres.2012.12.052
Surh YJ (2006) NF-κB and AP-1 as molecular targets for chemoprevention with EGCG, a review. Environ Chem Lett 4:137–141. https://doi.org/10.1007/s10311-006-0063-0
Suzuki T, Pervin M, Goto S, Isemura M, Nakamura Y (2016) Beneficial effects of tea and the green tea catechin epigallocatechin-3-gallate on obesity. Molecules 21:1305. https://doi.org/10.3390/molecules21101305
Tedeschi E, Menegazzi M, Yao Y, Suzuki H, Forstermann U, Kleinert H (2004) Green tea inhibits human inducible nitric-oxide synthase expression by down-regulating signal transducer and activator of transcription-1alpha activation. Mol Pharmacol 65:111–120. https://doi.org/10.1124/mol.65.1.111
Tiwari RP, Bharti SK, Kaur HD, Dikshit RP, Hoondal GS (2005) Synergistic antimicrobial activity of tea and antibiotics. Indian J Med Res 122:80–84
Treutter D (2006) Significance of flavonoids in plant resistance: a review. Environ Chem Lett 4:147–157. https://doi.org/10.1007/s10311-006-0068-8
Tripathy JP (2018) Burden and risk factors of diabetes and hyperglycemia in India: findings from the global burden of disease study 2016. Diabetes Metab Syndr Obes 11:381–387. https://doi.org/10.2147/DMSO.S157376
Velayutham P, Babu A, Liu D (2008) Green tea catechins and cardiovascular health: an update. Curr Med Chem 15(18):1840–1850. https://doi.org/10.2174/092986708785132979
Verloop AJW, Vincken JP, Gruppen H (2016) A tandem mass spectrometry method based on selected ions detects low abundance phenolics in black tea: theatridimensins as products of the oxidative cascade. Rapid Commun Mass Spectrom 30:1797–1805. https://doi.org/10.1002/rcm.7658
Vuong QV (2014) Epidemiological evidence linking tea consumption to human health: a review. Crit Rev Food Sci Nutr 54:523–536. https://doi.org/10.1080/10408398.2011.594184
Vuong QV, Bowyer MC, Roach PD (2011) L-Theanine: properties, synthesis and isolation from tea. J Sci Food Agric 91:1931–1939. https://doi.org/10.1002/jsfa.4373
Wakamatsu M, Yamanouchi H, Sahara H, Iwanaga T, Kuroda R, Yamamoto A, Minami Y, Sekijima M, Yamada K, Kajiya K (2019) Catechin and caffeine contents in green tea at different harvest periods and their metabolism in miniature swine. Food Sci Nut 7(8):2769–2778. https://doi.org/10.1002/fsn3.1143
Wang C, Li Y (2006) Research progress on property and application of Theaflavins. Afr J Biotechnol 5:213–218. https://doi.org/10.5897/AJB05.376
Weerawatanakorn M, Hung WL, Pan MH, Li S, Li D, Wan X, Ho CT (2015) Chemistry and health beneficial effects of oolong tea and theasinensins. Food Sci Hum Wellness. https://doi.org/10.1016/j.fshw.2015.10.002
Widlansky ME, Hamburg NM, Anter E, Holbrook M, Kahn DF, Elliott JG, Keaney JF Jr, Vita JA (2007) Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26:95–102. https://doi.org/10.1080/07315724.2007.10719590
Wiseman SA, Balentine DA, Frei B (1997) Antioxidants in tea. Crit Rev Food Sci Nut 37:705–718. https://doi.org/10.1080/10408399709527798
Yan Z, Zhong Y, Duan Y, Chen Q, Li F (2020) Antioxidant mechanism of tea polyphenols and its impact on health benefits. Anim Nutr 6:115–123. https://doi.org/10.1016/j.aninu.2020.01.001
Yang CS, Maliakal P, Meng X (2002) Inhibition of carcinogenesis by tea. Annu Rev Pharmacol Toxicol 42:25–54. https://doi.org/10.1146/annurev.pharmtox.42.082101.154309
Yang CS, Wang H (2011) Mechanistic issues concerning cancer prevention by tea catechins. Mol Nut Food Res 55:819–831. https://doi.org/10.1002/mnfr.201100036
Yang Z, Baldermann S, Watanabe N (2013) Recent studies of the volatile compounds in tea. Food Res Int 53:585–599. https://doi.org/10.1016/j.foodres.2013.02.011
Yi W, Hao C, Chen Y, Chen L, Fang Z, Liang L (2017) Formation of a multiligand complex of bovine serum albumin with retinol, resveratrol, and (−)-epigallocatechin-3-gallate for the protection of bioactive components. J Agric Food Chem 65:3019–3030. https://doi.org/10.1021/acs.jafc.7b00326
Yilmaz Y (2006) Novel uses of catechins in foods. Trends Food SciTech 17:64–71. https://doi.org/10.1016/j.tifs.2005.10.005
Zhang H, Jung J, Zhao Y (2016) Preparation, characterization and evaluation of antibacterial activity of catechins and catechins–Zn complex loaded β-chitosan nanoparticles of different particle sizes. Carbohydr Polym 137:82–91. https://doi.org/10.1016/j.carbpol.2015.10.036
Zhen YS (2002) Tea bioactivity and therapeutic potential. CRC Press, Taylor and Francis, London, U.K
Zhong Z, Dong Z, Yang L, Chen X, Gong Z (2012) Inhibition of proliferation of human lung cancer cells by green tea catechins is mediated by upregulation of let-7. Exp Ther Med 4:267–272. https://doi.org/10.3892/etm.2012.580
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Rana, A., Rana, S. & Kumar, S. Phytotherapy with active tea constituents: a review. Environ Chem Lett 19, 2031–2041 (2021). https://doi.org/10.1007/s10311-020-01154-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10311-020-01154-y